Nagai J - Search Results

1

Secreted PLA₂-III is a possible therapeutic target to treat neuropathic pain.

Tanaka K, Dozono N, Neyama H, Nagai J, Tsukahara R, Nagayasu K, Kaneko S, Ueda H. Tanaka K, et al. Among authors: nagai j. Biochem Biophys Res Commun. 2021 Sep 3;568:167-173. doi: 10.1016/j.bbrc.2021.06.058. Epub 2021 Jul 5. Biochem Biophys Res Commun. 2021. PMID: 34237486

2

Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.

Uchida H, Nagai J, Ueda H. Uchida H, et al. Among authors: nagai j. Mol Pain. 2014 Nov 19;10:71. doi: 10.1186/1744-8069-10-71. Mol Pain. 2014. PMID: 25411045 Free PMC article.

3

Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain.

Ueda H, Neyama H, Nagai J, Matsushita Y, Tsukahara T, Tsukahara R. Ueda H, et al. Among authors: nagai j. Pain. 2018 Nov;159(11):2170-2178. doi: 10.1097/j.pain.0000000000001316. Pain. 2018. PMID: 29939962

4

Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.

Ma L, Uchida H, Nagai J, Inoue M, Chun J, Aoki J, Ueda H. Ma L, et al. Among authors: nagai j. Mol Pain. 2009 Nov 13;5:64. doi: 10.1186/1744-8069-5-64. Mol Pain. 2009. PMID: 19912636 Free PMC article.

5

Evidence for de novo synthesis of lysophosphatidic acid in the spinal cord through phospholipase A2 and autotaxin in nerve injury-induced neuropathic pain.

Ma L, Uchida H, Nagai J, Inoue M, Aoki J, Ueda H. Ma L, et al. Among authors: nagai j. J Pharmacol Exp Ther. 2010 May;333(2):540-6. doi: 10.1124/jpet.109.164830. Epub 2010 Feb 1. J Pharmacol Exp Ther. 2010. PMID: 20123931

6

Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain.

Ma L, Nagai J, Ueda H. Ma L, et al. Among authors: nagai j. J Neurochem. 2010 Nov;115(3):643-53. doi: 10.1111/j.1471-4159.2010.06955.x. Epub 2010 Sep 6. J Neurochem. 2010. PMID: 20722972 Free article.

7

Pre-emptive morphine treatment abolishes nerve injury-induced lysophospholipid synthesis in mass spectrometrical analysis.

Nagai J, Ueda H. Nagai J, et al. J Neurochem. 2011 Jul;118(2):256-65. doi: 10.1111/j.1471-4159.2011.07297.x. Epub 2011 May 25. J Neurochem. 2011. PMID: 21542849 Free article.

8

Lysophosphatidic acid: chemical signature of neuropathic pain.

Ueda H, Matsunaga H, Olaposi OI, Nagai J. Ueda H, et al. Among authors: nagai j. Biochim Biophys Acta. 2013 Jan;1831(1):61-73. doi: 10.1016/j.bbalip.2012.08.014. Epub 2012 Aug 29. Biochim Biophys Acta. 2013. PMID: 22960381 Review.

9

Interleukin-1β plays key roles in LPA-induced amplification of LPA production in neuropathic pain model.

Yano R, Ma L, Nagai J, Ueda H. Yano R, et al. Among authors: nagai j. Cell Mol Neurobiol. 2013 Nov;33(8):1033-41. doi: 10.1007/s10571-013-9970-3. Epub 2013 Aug 15. Cell Mol Neurobiol. 2013. PMID: 23949386

10

Absence of morphine analgesia and its underlying descending serotonergic activation in an experimental mouse model of fibromyalgia.

Nishiyori M, Nagai J, Nakazawa T, Ueda H. Nishiyori M, et al. Among authors: nagai j. Neurosci Lett. 2010 Mar 26;472(3):184-7. doi: 10.1016/j.neulet.2010.01.080. Epub 2010 Feb 4. Neurosci Lett. 2010. PMID: 20138970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

438 results

Search Page